Logical Therapeutics
Logical Therapeutics develops drugs for the treatment of diseases caused by or related with excessive inflammation.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD92—138m (Dealroom.co estimates May 2010.)
Waltham Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | Series A | |
$30.0m | Series B | ||
N/A | $32.5m | Late VC | |
$16.9m | Series C | ||
Total Funding | CAD108m |